GlassScriptPhysician profile
Benjamin L Stivers
NPI 1447588009
$66,394.53
in general payments reported to CMS, 2019-2025
9 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.28 · 2020: $7,548 · 2021: $2,575 · 2022: $30K · 2023: $8,991 · 2024: $17K · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Food and Beverage: $1,653 · Travel and Lodging: $930 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,000.00 |
| Food and Beverage | $1,653.49 |
| Travel and Lodging | $930.34 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $65,574.16 | 2020-2025 | Da Vinci Surgical System |
| Davol INC. | $524.74 | 2019-2025 | Phasix Mesh |
| Ethicon US, LLC | $102.55 | 2020-2024 | Stratafix, Echelon Endopath, Echelon; Endopath |
| Ge Healthcare | $85.31 | 2024 | |
| Medtronic, INC. | $39.64 | 2021-2025 | Midas Rex |
| Myriad Genetic Laboratories, INC. | $24.63 | 2024 | Myrisk |
| Currax Pharmaceuticals LLC | $15.51 | 2023 | Contrave |
| Tela Bio, INC. | $14.45 | 2024 | Ovitex 2s |
| Janssen Biotech, INC. | $13.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Stivers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.